1. Home
  2. NL vs SLN Comparison

NL vs SLN Comparison

Compare NL & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NL Industries Inc.

NL

NL Industries Inc.

HOLD

Current Price

$5.79

Market Cap

283.9M

Sector

Industrials

ML Signal

HOLD

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

HOLD

Current Price

$6.25

Market Cap

318.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NL
SLN
Founded
1891
1994
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
283.9M
318.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NL
SLN
Price
$5.79
$6.25
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$39.67
AVG Volume (30 Days)
26.8K
317.2K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
9.90%
N/A
EPS Growth
N/A
N/A
EPS
0.20
N/A
Revenue
$159,004,000.00
$25,830,000.00
Revenue This Year
$15.75
N/A
Revenue Next Year
$2.44
N/A
P/E Ratio
$29.02
N/A
Revenue Growth
5.52
40.39
52 Week Low
$5.04
$1.97
52 Week High
$9.27
$8.08

Technical Indicators

Market Signals
Indicator
NL
SLN
Relative Strength Index (RSI) 54.72 45.38
Support Level $5.42 $6.12
Resistance Level $5.74 $6.72
Average True Range (ATR) 0.24 0.51
MACD 0.04 -0.05
Stochastic Oscillator 79.46 17.96

Price Performance

Historical Comparison
NL
SLN

About NL NL Industries Inc.

NL Industries Inc is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: